Meta Pixel

News and Announcements

Navigating the Emotional Challenges of Capital Raising: A Guide for Entrepreneurs

  • Published July 15, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

Embarking on the journey of raising capital for a business is often a challenging and emotional process. Entrepreneurs and founders face numerous hurdles, including the common experience of rejection and the associated emotional toll. However, it’s important to remember that these challenges are part of the journey, and resilience is key. This guide provides reassurance and insights, emphasising that you are not alone in this journey and offering transformative strategies that could significantly grow your business.

YouTube player

Founders often grapple with pressures from dwindling cash balances to the expectations of shareholders and board members. The importance of self-care, particularly the need for a good night’s sleep, and the power of reminding oneself of the reasons behind building the business cannot be overstated. The potential impact your business can have on team members and the creation of future job opportunities is another significant aspect to consider.

Turning the emotional aspects of capital raising into a more scientific approach can help navigate these challenges. Strategic conversations and clear decision-making are crucial in pursuing business growth. An inspiring example is a client who transformed their business through strategic acquisitions, emphasising the importance of resilience and a clear purpose.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now